Skip to main content
. Author manuscript; available in PMC: 2015 Jun 22.
Published in final edited form as: Leukemia. 2013 Mar 29;27(11):2177–2186. doi: 10.1038/leu.2013.91

Figure 5. Effect of JMJD3 shRNA transduction in cultured MDS bone marrow CD34+ cells.

Figure 5

(a) Numbers of myeloid colonies (CFU-G/M) and erythroid colonies (CFU-E) formed in methocult culture two weeks after transduction of JMJD3-shRNA and control shRNA in BM CD34+ cells isolated from patients with lower-risk MDS (low-risk and intermediate-1). (b) Representative microphotographs of colonies formed in methocult plates after transduction of control shRNA (Left panel) and JMJD3-shRNA (Right panel). Red arrows point to CFU-E. (c) Q-RTPCR analysis of the RNA levels of CD71, EPOR and GYPA in cells collected from total colonies after shRNA transduction and methocult assays.